What is the usual carboprost (Hemabate) dose for uterine bleeding?
Carboprost is commonly dosed for uterine atony and related postpartum hemorrhage under obstetric protocols. The standard regimen is 250 micrograms (0.25 mg) given by intramuscular injection, with repeat doses as needed based on uterine response and blood loss.
How is carboprost given (IM vs other routes)?
Carboprost dosing is typically intramuscular (IM) in obstetric use. Providers repeat dosing based on clinical response, monitoring for side effects and changes in uterine tone.
What happens if the first dose doesn’t work?
If bleeding continues after an initial IM dose, clinicians usually repeat carboprost at 0.25 mg increments and reassess response. The total number of doses and maximum cumulative dose depend on local protocol and patient factors (severity of hemorrhage, comorbidities, tolerability).
How much can you give before stopping (maximum dose)?
Protocols vary, but carboprost use in postpartum hemorrhage is generally limited by cumulative dosing and tolerability, with close monitoring of vital signs and adverse effects. If the uterus does not respond adequately, clinicians typically move to alternative therapies.
What doses are used for special populations?
Dose selection may change for patients with conditions that raise risk from carboprost’s side effects (for example, patients with significant asthma or bronchospasm risk). In those cases, clinicians may use more caution, adjust the dosing schedule, or choose alternative treatments.
What side effects are most tied to dosing?
Carboprost can cause dose-related and administration-related adverse effects such as:
- Diarrhea, nausea, vomiting
- Fever/chills
- Bronchospasm in susceptible patients (a key reason for careful history and monitoring)
If side effects are significant, clinicians may slow dosing, stop carboprost, or switch to another postpartum hemorrhage medication.
Are dosing amounts different for other carboprost indications?
Carboprost dosing depends on the indication and protocol. If you mean a non-obstetric use (for example, other gynecologic indications), tell me the context and route, because the dose can differ.
If you confirm what you mean by “carboprost dose” (postpartum hemorrhage/uterine atony, dose per IM injection, route, and patient age/pregnancy context), I can narrow it to the most relevant regimen.